Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
Jun. 30, 2013
Dec. 31, 2012
Current Assets:    
Cash $ 76,670 $ 431
Accounts Receivable 1,561,496  
Total current assets 1,638,166 431
Other Current Assets    
Prepaid Inventory 975,471  
Inventory 2,177,823  
Total Other Current Assets 3,153,294  
Total Current Assets 4,791,460 431
Property and Equipment, Net 18,315  
Other Assets    
Goodwill 1,855,512  
Intangibles, Net 3,767,500  
Investment in Kannalife 500,000  
Total Other Assets 6,123,012  
TOTAL ASSETS 10,932,787 431
Current Liabilities:    
Accounts payable 27,134  
Accrued interest 20,523  
Amount due to related party 300 500
Other Current Liabilities    
PhytoSphere Agreement 4,963,906 0
Total Current Liabilities 5,011,863 500
Long Term Liabilities    
Line of Credit - Roen Ventures LLC 3,280,500  
Total Long Term Liabilities 3,280,500  
TOTAL LIABILITIES 8,292,363 500
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred stock, par value $0.0001; 10,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock - par value $0.0001; 190,000,000 shares authorized; 8,900,000 and 7,000,000 shares issued and outstanding as of June 30, 2013 and December 31, 2012 respectively 890 700
Additional paid in capital 2,449,351 143,447
Retained Earnings (Accumulated Deficit) 190,183 (144,216)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) 2,640,424 (69)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 10,932,787 $ 431